Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-25-021872

Options or other derivatives

  • Interim CEO & General Counsel acquired 187,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-05 Grant or award : show line 1 in the form Restricted Stock Units +187,500 187,500 D
Loading xslF345X05/tm258333-10_4seq1.xml…